Stocks · Health care · Surgical & Medical Instruments & Apparatus

Becton Dickinson

BDX Clue Score44
United States Fiscal year ends September CIK 0000010795
183.75
+0.55%
Close, 9 Oct 2026 · USD

Price, with every insider trade on it

Closing prices, 12 months · point at a dot for who traded, or at the line for the close
183.75 on 9 Oct 2026
210 175 141 Oct 2025 Apr 2026 Oct 2026 13 Oct 2025 $186.66 14 Oct 2025 $188.36 15 Oct 2025 $186.77 16 Oct 2025 $185.27 17 Oct 2025 $189.10 20 Oct 2025 $191.00 21 Oct 2025 $189.03 22 Oct 2025 $188.11 23 Oct 2025 $186.53 24 Oct 2025 $185.83 27 Oct 2025 $187.04 28 Oct 2025 $184.21 29 Oct 2025 $181.52 30 Oct 2025 $179.38 31 Oct 2025 $178.71 3 Nov 2025 $177.30 4 Nov 2025 $179.04 5 Nov 2025 $176.39 6 Nov 2025 $177.39 7 Nov 2025 $177.84 10 Nov 2025 $181.64 11 Nov 2025 $189.02 12 Nov 2025 $192.12 13 Nov 2025 $193.04 14 Nov 2025 $193.04 17 Nov 2025 $190.98 18 Nov 2025 $192.33 19 Nov 2025 $191.22 20 Nov 2025 $189.58 21 Nov 2025 $192.72 24 Nov 2025 $190.96 25 Nov 2025 $195.49 26 Nov 2025 $193.90 28 Nov 2025 $194.02 1 Dec 2025 $191.82 2 Dec 2025 $190.47 3 Dec 2025 $193.57 4 Dec 2025 $193.76 5 Dec 2025 $193.96 8 Dec 2025 $189.50 9 Dec 2025 $188.82 10 Dec 2025 $198.40 11 Dec 2025 $200.43 12 Dec 2025 $200.89 15 Dec 2025 $200.09 16 Dec 2025 $196.39 17 Dec 2025 $195.36 18 Dec 2025 $194.70 19 Dec 2025 $195.59 22 Dec 2025 $196.74 23 Dec 2025 $195.67 24 Dec 2025 $196.12 26 Dec 2025 $196.33 29 Dec 2025 $195.16 30 Dec 2025 $195.64 31 Dec 2025 $194.07 2 Jan 2026 $194.94 5 Jan 2026 $198.96 6 Jan 2026 $205.36 7 Jan 2026 $202.71 8 Jan 2026 $205.18 9 Jan 2026 $202.75 12 Jan 2026 $202.74 13 Jan 2026 $201.52 14 Jan 2026 $207.42 15 Jan 2026 $208.35 16 Jan 2026 $207.11 20 Jan 2026 $203.39 21 Jan 2026 $206.18 22 Jan 2026 $206.04 23 Jan 2026 $201.79 26 Jan 2026 $203.42 27 Jan 2026 $203.40 28 Jan 2026 $201.92 29 Jan 2026 $201.09 30 Jan 2026 $203.48 2 Feb 2026 $201.91 3 Feb 2026 $206.50 4 Feb 2026 $207.87 5 Feb 2026 $206.51 6 Feb 2026 $210.02 9 Feb 2026 $207.39 10 Feb 2026 $171.68 11 Feb 2026 $180.62 12 Feb 2026 $177.81 13 Feb 2026 $175.89 17 Feb 2026 $177.38 18 Feb 2026 $182.68 19 Feb 2026 $182.47 20 Feb 2026 $185.39 23 Feb 2026 $184.34 24 Feb 2026 $182.49 25 Feb 2026 $180.96 26 Feb 2026 $176.66 27 Feb 2026 $176.48 2 Mar 2026 $176.54 3 Mar 2026 $174.21 4 Mar 2026 $171.49 5 Mar 2026 $169.94 6 Mar 2026 $167.12 9 Mar 2026 $165.46 10 Mar 2026 $163.88 11 Mar 2026 $163.17 12 Mar 2026 $159.63 13 Mar 2026 $159.36 16 Mar 2026 $160.27 17 Mar 2026 $161.64 18 Mar 2026 $158.08 19 Mar 2026 $156.53 20 Mar 2026 $154.13 23 Mar 2026 $156.23 24 Mar 2026 $155.92 25 Mar 2026 $158.27 26 Mar 2026 $157.38 27 Mar 2026 $154.51 30 Mar 2026 $154.69 31 Mar 2026 $157.23 1 Apr 2026 $156.34 2 Apr 2026 $154.51 6 Apr 2026 $155.32 7 Apr 2026 $154.96 8 Apr 2026 $157.09 9 Apr 2026 $155.46 10 Apr 2026 $154.22 13 Apr 2026 $155.43 14 Apr 2026 $155.73 15 Apr 2026 $155.52 16 Apr 2026 $154.82 17 Apr 2026 $158.54 20 Apr 2026 $158.64 21 Apr 2026 $156.69 22 Apr 2026 $155.65 23 Apr 2026 $154.85 24 Apr 2026 $152.14 27 Apr 2026 $150.22 28 Apr 2026 $149.52 29 Apr 2026 $145.31 30 Apr 2026 $149.04 1 May 2026 $149.31 4 May 2026 $146.31 5 May 2026 $144.17 6 May 2026 $144.76 7 May 2026 $153.26 8 May 2026 $149.43 11 May 2026 $143.15 12 May 2026 $147.51 13 May 2026 $144.18 14 May 2026 $144.47 15 May 2026 $143.47 18 May 2026 $142.35 19 May 2026 $146.95 20 May 2026 $146.95 21 May 2026 $146.25 22 May 2026 $147.63 26 May 2026 $147.75 27 May 2026 $147.24 28 May 2026 $148.41 29 May 2026 $147.12 1 Jun 2026 $145.33 2 Jun 2026 $144.43 3 Jun 2026 $145.61 4 Jun 2026 $149.56 5 Jun 2026 $151.16 8 Jun 2026 $149.99 9 Jun 2026 $152.04 10 Jun 2026 $147.79 11 Jun 2026 $147.35 12 Jun 2026 $146.24 15 Jun 2026 $145.52 16 Jun 2026 $145.16 17 Jun 2026 $141.61 18 Jun 2026 $143.98 22 Jun 2026 $140.71 23 Jun 2026 $143.92 24 Jun 2026 $147.77 25 Jun 2026 $151.38 26 Jun 2026 $155.92 29 Jun 2026 $155.19 30 Jun 2026 $151.33 1 Jul 2026 $152.90 2 Jul 2026 $158.08 6 Jul 2026 $155.54 7 Jul 2026 $156.30 8 Jul 2026 $150.56 9 Jul 2026 $150.85 10 Jul 2026 $151.94 13 Jul 2026 $153.83 14 Jul 2026 $150.65 15 Jul 2026 $154.88 16 Jul 2026 $159.93 17 Jul 2026 $158.17 20 Jul 2026 $154.48 21 Jul 2026 $153.84 22 Jul 2026 $153.16 23 Jul 2026 $152.97 24 Jul 2026 $156.36 27 Jul 2026 $158.92 28 Jul 2026 $166.34 29 Jul 2026 $168.40 30 Jul 2026 $165.45 31 Jul 2026 $165.62 3 Aug 2026 $170.21 4 Aug 2026 $170.12 5 Aug 2026 $170.66 6 Aug 2026 $177.07 7 Aug 2026 $176.86 10 Aug 2026 $179.63 11 Aug 2026 $181.41 12 Aug 2026 $183.58 13 Aug 2026 $181.97 14 Aug 2026 $183.40 17 Aug 2026 $182.09 18 Aug 2026 $180.77 19 Aug 2026 $187.60 20 Aug 2026 $187.62 21 Aug 2026 $192.00 24 Aug 2026 $190.74 25 Aug 2026 $189.78 26 Aug 2026 $190.21 27 Aug 2026 $188.13 28 Aug 2026 $189.52 31 Aug 2026 $188.11 1 Sep 2026 $187.12 2 Sep 2026 $187.52 3 Sep 2026 $187.62 4 Sep 2026 $184.74 8 Sep 2026 $179.10 9 Sep 2026 $179.80 10 Sep 2026 $176.42 11 Sep 2026 $177.85 14 Sep 2026 $182.91 15 Sep 2026 $185.92 16 Sep 2026 $181.85 17 Sep 2026 $181.38 18 Sep 2026 $180.94 21 Sep 2026 $180.70 22 Sep 2026 $183.00 23 Sep 2026 $182.52 24 Sep 2026 $179.23 25 Sep 2026 $183.82 28 Sep 2026 $183.83 29 Sep 2026 $181.97 30 Sep 2026 $179.00 1 Oct 2026 $178.07 2 Oct 2026 $176.80 5 Oct 2026 $180.67 6 Oct 2026 $180.30 7 Oct 2026 $180.16 8 Oct 2026 $182.75 9 Oct 2026 $183.75 Feld Michael EVP & President, Life Sciences Sold on a plan $10.60K 27 Oct 2025 · at $186.01 · 0.7% of stake SCOTT BERTRAM L Director Sold at will $38.32K 7 Nov 2025 · at $176.58 · 0.6% of stake Feld Michael EVP, CRO & Pres. Life Sciences Sold on a plan $14.50K 1 Dec 2025 · at $193.36 · 0.5% of stake Garrison Michael David EVP & Pres Med.Essntl&BioPharm Sold on a plan $123.30K 17 Dec 2025 · at $196.03 · 4.6% of stake Feld Michael EVP, CRO & Pres. Life Sciences Sold on a plan $14.51K 26 Dec 2025 · at $196.08 · 0.4% of stake Garrison Michael David EVP & Pres Med.Essntl&BioPharm Sold on a plan $334.01K 15 Jan 2026 · at $207.46 · 11.7% of stake Feld Michael EVP, CRO & Pres. Life Sciences Sold on a plan $15.20K 26 Jan 2026 · at $202.73 · 0.5% of stake SCOTT BERTRAM L Director Sold at will $174.03K 18 Feb 2026 · at $182.61 · 2.5% of stake Feld Michael EVP, Chief Revenue Officer Sold on a plan $13.64K 26 Feb 2026 · at $181.84 · 0.4% of stake Feld Michael EVP, Chief Revenue Officer Sold on a plan $11.76K 26 Mar 2026 · at $156.83 · 0.4% of stake Feld Michael EVP, Chief Revenue Officer Sold on a plan $11.24K 27 Apr 2026 · at $151.94 · 0.3% of stake Feld Michael EVP, Chief Revenue Officer Sold on a plan $11.05K 26 May 2026 · at $147.35 · 0.4% of stake Polen Thomas E Jr Chairman, CEO and President Sold on a plan $404.51K 1 Jun 2026 · at $146.35 · 2.4% of stake Garrison Michael David EVP & Pres Med.Essntl&BioPharm Sold on a plan $166.63K 10 Jun 2026 · at $151.48 · 7.2% of stake Garrison Michael David EVP & Pres Med.Essntl&BioPharm Sold on a plan $160.23K 24 Jun 2026 · at $145.66 · 7.7% of stake Feld Michael EVP, Chief Revenue Officer Sold on a plan $11.46K 26 Jun 2026 · at $152.80 · 0.4% of stake Feld Michael EVP, Chief Revenue Officer Sold on a plan $11.78K 27 Jul 2026 · at $157.13 · 0.4% of stake Goette Roland EVP and President, EMEA Sold at will $440.89K 11 Aug 2026 · at $180.84 · 14.1% of stake Polen Thomas E Jr Chairman, CEO and President Sold on a plan $768.12K 13 Aug 2026 · at $185.00 · 3.6% of stake Feld Michael EVP, Chief Revenue Officer Sold on a plan $31.10K 26 Aug 2026 · at $188.49 · 0.8% of stake Feld Michael EVP, Chief Revenue Officer Sold on a plan $13.96K 28 Sep 2026 · at $183.70 · 0.4% of stake
0 buys3 sales at will18 planned sales

Key numbers

Fiscal year 2025, ended 30 Sep 2025, as filed
Revenue
$21.84B
Net income
$1.68B
Free cash flow
$2.67B
Operating margin
11.8%
Net margin
7.7%
Return on equity
6.6%
Return on capital
5.4%
Debt to equity
0.69
Revenue growth, 1 yr
8.2%
Revenue growth, 5 yr
6.3% a year
EPS growth, 1 yr
-0.7%

Revenue and net income

Fiscal years, as filed with the SEC · point at a year for the detail
16.1B 874M FY20 Fiscal year 2020 Revenue $16.07B Net income $874.00M Margin 5.4% 19.1B 2.1B FY21 Fiscal year 2021 Revenue $19.13B Net income $2.09B Margin 10.9% · growth +19.0% 18.9B 1.8B FY22 Fiscal year 2022 Revenue $18.87B Net income $1.78B Margin 9.4% · growth -1.4% 19.4B 1.5B FY23 Fiscal year 2023 Revenue $19.37B Net income $1.48B Margin 7.7% · growth +2.7% 20.2B 1.7B FY24 Fiscal year 2024 Revenue $20.18B Net income $1.71B Margin 8.4% · growth +4.2% 21.8B 1.7B FY25 Fiscal year 2025 Revenue $21.84B Net income $1.68B Margin 7.7% · growth +8.2%
RevenueNet incomeLoss

Latest insider transactions

From Form 4, most recent first
All of them →
DateInsiderTypeValueOf own stake
28 Sep 2026 Feld Michael
EVP, Chief Revenue Officer
Sold on a plan $13.96K 0.4%
26 Aug 2026 Feld Michael
EVP, Chief Revenue Officer
Sold on a plan $31.10K 0.8%
13 Aug 2026 Polen Thomas E Jr
Chairman, CEO and President
Sold on a plan $768.12K 3.6%
11 Aug 2026 Goette Roland
EVP and President, EMEA
Sold at will $440.89K 14.1%
27 Jul 2026 Feld Michael
EVP, Chief Revenue Officer
Sold on a plan $11.78K 0.4%
26 Jun 2026 Feld Michael
EVP, Chief Revenue Officer
Sold on a plan $11.46K 0.4%